Hi at all.
I'm sorry for this my post, I haven't fibromyalgia and I'm not a medical doctor. Then, why have I to write in this forum?
Let me a brief presentation: I'm a chemistry who is working on epilepsy since 1981, the same year of I was graduate, at the University of Genova, Italy. Thanks to the results of my studies I discovered a whey protein, alpha-lactalbumin (ALAC), able to control epileptic seizures. Thanks to the results obtained both in human both in animals ALAC is actually in the screening program of NIH (US). But this is another story.
Recently I was interested to fibromyalgia, then I was reading international forum, too, to verify different ideas on this pathology.
I looked for ALAC because the Markus’s papers reporting ALAC to be able to increase plasmatic tryptophan (trp), in fact, ALAC has been reported to be rich in trp and poor in the other amino acids competing with the BBB carrier, the LNAAs. But the trp levels are increased not by the trp arising from ALAC, but by the result of ALAC effects on intestine. Many intestinal actions are reported for ALAC, it’s able to decrease intestinal dysbiosis that is responsible of trp decarboxylation in indole and skatole. Urinary levels of these catabolites are markers of dysbiosis. Low trp/LNAA plasmatic ratio is reported in epileptic pts, I was able to evaluate an third reduction in brain trp uptake in epileptics vs controls. Furthermore high skatole levels are reported in urine of epileptic pts.
Trp is not only the only serotonin precursor, its intestinal level controls the brain synthesis of neuropeptides, i.e. NPY. NPY is named an endogenous anticonvulsant for the high anticonvulsant effect when it’s directly injected in the brain of animals. But NPY is responsible of pain threshold, too. Low trp intestinal levels correspond to low brain levels of NPY, then to a low pain threshold.
Fatigue and pain are reported in many neurological diseases, i.e. MS and Parkinson. In 1978 Monaco and Mutani reported low trp/LNAA plasmatic ratio in MS pts.
Different symptoms are linked to fibromyalgia, i.e. sleep disorders, rheumatoid arthritis (RA) . Sleep disorders are correlated with low serotonin levels in the brain. In experimental models of sleep disorders ALAC has been reported to be able to improve sleep, improving the time spent in deep sleep. RA is linked to elevate intestinal permeability, that it’s correlate with dysbiosis.
Please read forum rules. You are giving medical advice here. Post Edited By Moderator (Sherrine) : 8/18/2010 5:01:52 PM (GMT-6)